Soler, J, Borao, L, Schmidt, C, Martinez-Rubio, D, Cebolla, A, Montero-Marin, J, García-Campayo, J, Gascon-Santos, S, Pascual, JC. Two exploratory studies to investigate the role of self and emotional dysregulation in borderline personality disorder. EUROPEAN JOURNAL OF PSYCHIATRY. 2026; 40(2)DOI:10.1016/j.ejpsy.2026.100347. PMID:. IF:1.500(Q3/7D).

Grasa, E, Forment, A, Alonso-Solís, A, Ramalho, L, Roldán, A, Pousa, E, Aussó, S, Berdun, J, Tesoro, AG, Escudero, J, Corripio, I. Defining the Patient Journey and Identifying Digital Health Solutions in Treatment-Resistant Schizophrenia. ACTAS ESPANOLAS DE PSIQUIATRIA. 2025; 53(6)DOI:10.62641/aep.v53i6.1959. PMID:41437755. IF:1.600(Q3/7D).

Palazón-Llecha, A, Trujols, J, Madre, M, Duran-Sindreu, S, Batlle, F, Mallorquí-Bagué, N. Compulsive sexual behavior in cocaine use disorder: Treatment outcomes and clinical challenges. ACTA PSYCHOLOGICA. 2026; 264DOI:10.1016/j.actpsy.2026.106574. PMID:41812393. IF:2.700(Q2/3D).

Ramos, JR, Rovira, MC, Sindreu, MDC, Marquez, PP, Carrillo, SZ, Rios, IP, Egea, ER, Blas, FS, Planella, MP, Piera, OM, Campmany, MP. Pharmacological management of an agitated patient in the emergency department. Pharmaceutical Care Espana. 2026; 28DOI:10.60103/phc.v27.e920. PMID:. IF:(Q/D).

Hong, SJ, Dobricic, V, Ohlei, O, Bos, I, Vos, SJB, Prokopenko, D, Tijms, BM, Andreasson, U, Blennow, K, Vandenberghe, R, Gabel, S, Scheltens, P, Teunissen, CE, Engelborghs, S, Frisoni, G, Blin, O, Richardson, JC, Bordet, R, Lleo, A, Alcolea, D, Popp, J, Clark, C, Peyratout, G, Martinez-Lage, P, Tainta, M, Dobson, RJB, Legido-Quigley, C, Sleegers, K, Van Broeckhoven, C, Tanzi, RE, ten Kate, M, Wittig, M, Franke, A, Lill, CM, Barkhof, F, Lovestone, S, Streffer, J, Zetterberg, H, Visser, PJ, Bertram, L, Neuroimaging Initiative. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels. ALZHEIMERS & DEMENTIA. 2021; 17(10)DOI:10.1002/alz.12330. PMID:33991015. IF:16.655(Q1/1D).

Cabello-Toscano, M, Vaqué-Alcázar, L, Bayes-Marin, I, Cattaneo, G, Solana-Sánchez, J, Mulet-Pons, L, Bargalló, N, Tormos, JM, Pascual-Leone, A, Bartrés-Faz, D. Functional brain connectivity prior to the COVID-19 outbreak predicts mental health trajectories during two years of pandemic. PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2024; 78(4)DOI:10.1111/pcn.13654. PMID:38372461. IF:6.200(Q1/1D).

Toapanta, N, Comas, J, Revuelta, I, Manonelles, A, Facundo, C, Pérez-Saez, MJ, Vila, A, Arcos, E, Tort, J, Giral, M, Naesens, M, Kuypers, D, Asberg, A, Moreso, F, Bestard, O. Benefits of Living Over Deceased Donor Kidney Transplantation in Elderly Recipients. A Propensity Score Matched Analysis of a Large European Registry Cohort. TRANSPLANT INTERNATIONAL. 2024; 37DOI:10.3389/ti.2024.13452. PMID:39263600. IF:3.000(Q1/1D).

Aceituno, L, Nuñez-Conde, A, Serra-Pladevall, J, Viñado, B, Castella, E, Escolà-Vergé, L, Pigrau, C, Falcó, V, Len, YO. Oral quinolones versus intravenous ß-lactam for the treatment of acute focal bacterial nephritis: a retrospective cohort study. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2024; 43(8)DOI:10.1007/s10096-024-04871-2. PMID:38856826. IF:3.000(Q2/4D).

Diaz-Torne, C, Pou, MA, Horne, A, Gasteiger, C, Dalbeth, N. 'Gout was like the boss'. A qualitative study exploring the impact of gout on employment. RMD Open. 2024; 10(3)DOI:10.1136/rmdopen-2024-004443. PMID:39160089. IF:4.700(Q1/1D).

Codes-Méndez, H, Sainz, L, Park, HS, Corominas, H, Diaz-Torne, C. Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD Open. 2024; 10(2)DOI:10.1136/rmdopen-2024-004173. PMID:38626930. IF:4.700(Q1/1D).

Arismendi, E, Puente-Maestu, L, Domingo, C, Dávila, I, Quirce, S, González-Barcala, FJ, Crespo-Lessmann, A, Sánchez-Jareño, M, Rivas-Pardinas, C, Cea-Calvo, L. Diagnosed and undiagnosed cough-related stress urinary incontinence in women with refractory or unexplained chronic cough: Its impact on general health status and quality of life. Chronic Respiratory Disease. 2024; 21DOI:10.1177/14799731241273751. PMID:39222070. IF:2.300(Q2/5D).

Behrens, GMN, Assoumou, L, Liegeon, G, Antinori, A, Micán, R, Genderini, FG, Post, FA, Rockstroh, JK, Hamzah, L, Domingo, P, Curran, A, Laguno, M, Fletcher, C, Moody, J, Pozniak, A. Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial. LANCET INFECTIOUS DISEASES. 2026; 26(5)DOI:10.1016/S1473-3099(25)00681-4. PMID:41344354. IF:31.000(Q1/1D).

Català-Moll, F, Blázquez-Bondia, C, Farré-Badia, J, Torres, F, Manzardo, C, Bonfill, E, Curran, A, Domingo, P, Podzamczer, D, Force, L, Falcó, V, Parera, M, Casadellà, M, Miró, JM, Noguera-Julian, M, Paredes, R. Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. Nature Communications. 2026; 17(1)DOI:10.1038/s41467-026-69846-7. PMID:41781390. IF:15.700(Q1/1D).

de Lazzari, E, Negredo, EB, Domingo, P, Tiraboschi, JM, Ribera, E, Abdulghani, N, Alba, V, Fernández-Arroyo, S, Viladés, C, Peraire, J, Gatell, JM, Blanco, JL, Vidal, F, Rull, A, Martinez, E. Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024; 79(5)DOI:10.1093/jac/dkae083. PMID:38546974. IF:3.600(Q2/3D).

Nomah, DK, Jamarkattel, S, Bruguera, A, Moreno-Fornés, S, Díaz, Y, Alonso, L, Aceitón, J, Llibre, JM, Domingo, P, Saumoy, M, Homar, F, Fanjul, F, Navarro, J, de la Mora, L, Knobel, H, Orti, A, Martin-Iguacel, R, Miró, JM, Casabona, J, Reyes-Urueña, J. Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998-2020. Open Forum Infectious Diseases. 2024; 11(4)DOI:10.1093/ofid/ofae132. PMID:38560603. IF:3.800(Q1/3D).

Fernandez Montes A., Elez E., de la Haba-Rodriguez J., Paez D., Mendez-Vidal M.J., Felip E., Rodriguez-Lescure A.. Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology. Clinical & Translational Oncology. 2024; 26DOI:10.1007/s12094-023-03225-2. PMID:37316754. IF:2.500(Q3/6D).

Baldi, GG, Giani, C, Ljevar, S, Denu, RA, Napolitano, A, Han, I, Brunello, A, Bhadri, V, Sebio, A, Andelkovic, V, Campos, F, Scanferla, R, Abreu, MH, Desar, IME, Ogura, K, Wong, DD, Bae, S, Bakhshi, S, Lefler, DS, Marquina, G, Mazzocca, A, Nakazawa, MS, Thway, K, Kim, HS, Chiusole, B, Connolly, EA, Terés, R, Antonescu, C, Bellan, E, Bovee, JVMG, Davis, JL, Tos, APD, Di Blasi, E, Lazar, AJ, Sbaraglia, M, Schaefer, IM, Taverna, S, Gronchi, A, Miceli, R, Chen, TW, Stacchiotti, S. Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium. EUROPEAN JOURNAL OF CANCER. 2026; 238DOI:10.1016/j.ejca.2026.116666. PMID:41819027. IF:7.100(Q1/2D).

Novello, S, Rabinovich, NM, Shih, JY, Pelizzari, G, Stevenson, J, Majem, M, Ferreira, CG, Petty, WJ, Arriola, E, Castagneris, N, De Castro, J, Morbeck, I, Bauman, J, Toschi, L, Zer, A, Metro, G, Kalmadi, S, Martinez, AA, Al Husaini, H, Meloni, AR, Nduka, C, Ardito-Abraham, C, Xia, CH, Awad, MM. Sotorasib in Advanced KRAS G12C-Mutated NSCLC Results From the Global Expanded Access Program Including Patients With Poor Performance Status and a History of CNS Metastases. Jto Clinical And Research Reports. 2026; 7(5)DOI:10.1016/j.jtocrr.2026.100974. PMID:42006282. IF:(Q/D).

Espinosa, E, Berciano-Guerrero, MA, Muñoz-Couselo, E, Puértolas, T, Manzano, JL, Soria, A, De Miguel, PA, Crespo, G, Sanz, LG, Cerezuela-Fuentes, P, de la Rosa, CA, Majem, M, Castaño, AG, Berrocal, A, Arroyo, FRG, de la Borbolla, MR, Bellido, L, Martínez, JM, Fernández, LA, Carnicero, AM, Castro, RL, Rodríguez, AB, Lecumberri, MJ, Guzmán, JCV, Balea, BC, Rodríguez, JF, Bautista, JV, Pérez, VN, Mujika, K, Subias, MC, Hernández, B, Algarra, SM, Márquez-Rodas, I. Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801. Clinical & Translational Oncology. 2026; 28(5)DOI:10.1007/s12094-025-04098-3. PMID:41313559. IF:2.500(Q3/6D).

Sierra-Rodero, B, Gil-González, A, Molina-Alejandre, M, Nadal, E, Calvo, V, Lázaro, M, Insa, A, Massuti, B, Marti, AM, de Castro, J, Campelo, RG, Larriba, JLG, Bernabé, R, Dómine, M, Aix, SP, Cobo, M, Camps, C, Reguart, N, Bosch-Barrera, J, Majem, M, Aguilar, A, Palmero, R, Clemente, MB, Martín-López, J, Muñoz-Viana, R, Megías, D, Gutiérrez-Escobedo, JM, Martínez-Toledo, C, Cruz-Bermúdez, A, Provencio, M. Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer. CLINICAL CANCER RESEARCH. 2026; 32(8)DOI:10.1158/1078-0432.CCR-25-3315. PMID:41805895. IF:10.200(Q1/1D).